Skip to content
healthcare.dev

ARYNTA

NDC 24338-162, lisdexamfetamine dimesylate oral, solution, from Azurity Pharmaceuticals, Inc..

Product NDC
24338-162
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219847
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24338-162 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE10 mg/mL

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
24338-162-01243380162011 BOTTLE in 1 CARTON (24338-162-01) / 120 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/71cdfc97-96af-4378-a44a-6d5d77e7d6b7

Use it

Look up 24338-162 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24338-162 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24338-162. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.